Skip to main content
INBIOGEN CO.,Ltd logo

INBIOGEN CO.,Ltd — Investor Relations & Filings

Ticker · 101140 ISIN · KR7101140002 KO Professional, scientific and technical activities
Open in API
Filings indexed 342 across all filing types
Latest filing 2021-05-31 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 101140

About INBIOGEN CO.,Ltd

https://www.inbiogen.com/

INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.

Recent filings

Filing Released Lang Actions
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is an official regulatory filing from the Korea Exchange (KRX) regarding the results of a capital increase (paid-in capital increase/issuance of convertible preferred shares). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2021-05-31 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a '주요사항보고서(유상증자결정)' (Major Report: Decision on Paid-in Capital Increase) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange). It details a capital increase through a third-party allocation, including specific share counts, pricing, and the purpose of the funds. This type of filing is a standard regulatory disclosure regarding changes in capital structure and share issuance, which falls under the 'Share Issue/Capital Change' category.
2021-05-18 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the 1st quarter of the 14th fiscal year (2021-01-01 to 2021-03-31) for Inbiogen Co., Ltd. It contains detailed corporate information, history, capital changes, and governance details, which are standard components of a formal quarterly financial report filed with the Financial Services Commission and the Korea Exchange. It is not an announcement or a certification, but the report itself. Q1 2021
2021-05-17 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) filed with the Financial Services Commission/Korea Exchange. It details specific amendments (정정신고) to the terms of a third-party capital increase, including changes to payment dates, share issuance details, and conversion rights. This falls under the category of announcements regarding share issues and capital structure changes.
2021-04-30 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing titled '정정신고(보고)' (Correction Report) regarding the issuance of convertible bonds ('전환사채권 발행결정'). It details specific amendments to the terms of the bond issuance, such as maturity dates, conversion periods, and call/put option details. This is a standard corporate disclosure document filed with the financial regulatory authorities (Financial Services Commission/Korea Exchange) to update previously submitted information. It falls under the category of capital and financing updates.
2021-04-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend status, and board appointments. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), as it reports the official outcomes of shareholder votes at an AGM.
2021-03-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.